Ticagrelor for the Comatose

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The study will investigate the effect of the oral antiplatelet agent ticagrelor (Brilique) when it is administrated through a nasogastric tube in comatose patients. The platelet function can be determined by various platelet function tests (PFT), Multiplate and VerifyNow . As control, the reference intervals from the literature are used. Futhermore, plasma concentrations of the active metabolite will be determined at aeveral timepoints after first intake of a bolus dose.
Epistemonikos ID: 26797d6c45e74993c4d8aa0a035969029667828b
First added on: May 11, 2024